These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
537 related articles for article (PubMed ID: 30240060)
1. Astrocytes, the rising stars of the glioblastoma microenvironment. Brandao M; Simon T; Critchley G; Giamas G Glia; 2019 May; 67(5):779-790. PubMed ID: 30240060 [TBL] [Abstract][Full Text] [Related]
2. Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma. Zhang H; Zhou Y; Cui B; Liu Z; Shen H Biomed Pharmacother; 2020 Jun; 126():110086. PubMed ID: 32172060 [TBL] [Abstract][Full Text] [Related]
3. Pre-Clinical Drug Testing in 2D and 3D Human In Vitro Models of Glioblastoma Incorporating Non-Neoplastic Astrocytes: Tunneling Nano Tubules and Mitochondrial Transfer Modulates Cell Behavior and Therapeutic Respons. Civita P; M Leite D; Pilkington GJ Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795330 [TBL] [Abstract][Full Text] [Related]
4. A co-culture model with brain tumor-specific bioluminescence demonstrates astrocyte-induced drug resistance in glioblastoma. Yang N; Yan T; Zhu H; Liang X; Leiss L; Sakariassen PØ; Skaftnesmo KO; Huang B; Costea DE; Enger PØ; Li X; Wang J J Transl Med; 2014 Oct; 12():278. PubMed ID: 25280402 [TBL] [Abstract][Full Text] [Related]
5. A human co-culture cell model incorporating microglia supports glioblastoma growth and migration, and confers resistance to cytotoxics. Leite DM; Zvar Baskovic B; Civita P; Neto C; Gumbleton M; Pilkington GJ FASEB J; 2020 Jan; 34(1):1710-1727. PubMed ID: 31914660 [TBL] [Abstract][Full Text] [Related]
7. Chemoresistance caused by the microenvironment of glioblastoma and the corresponding solutions. Zhang X; Ding K; Wang J; Li X; Zhao P Biomed Pharmacother; 2019 Jan; 109():39-46. PubMed ID: 30391707 [TBL] [Abstract][Full Text] [Related]
12. Astrocytes enhance glioblastoma growth. Mega A; Hartmark Nilsen M; Leiss LW; Tobin NP; Miletic H; Sleire L; Strell C; Nelander S; Krona C; Hägerstrand D; Enger PØ; Nistér M; Östman A Glia; 2020 Feb; 68(2):316-327. PubMed ID: 31509308 [TBL] [Abstract][Full Text] [Related]
13. Smac Mimetic-Induced Upregulation of CCL2/MCP-1 Triggers Migration and Invasion of Glioblastoma Cells and Influences the Tumor Microenvironment in a Paracrine Manner. Lindemann C; Marschall V; Weigert A; Klingebiel T; Fulda S Neoplasia; 2015 Jun; 17(6):481-9. PubMed ID: 26152356 [TBL] [Abstract][Full Text] [Related]
14. Breaking through the glioblastoma micro-environment via extracellular vesicles. Simon T; Jackson E; Giamas G Oncogene; 2020 Jun; 39(23):4477-4490. PubMed ID: 32366909 [TBL] [Abstract][Full Text] [Related]
15. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment. Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064 [TBL] [Abstract][Full Text] [Related]
16. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma. Barone TA; Burkhart CA; Safina A; Haderski G; Gurova KV; Purmal AA; Gudkov AV; Plunkett RJ Neuro Oncol; 2017 Feb; 19(2):186-196. PubMed ID: 27370399 [TBL] [Abstract][Full Text] [Related]
17. Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies. Fanelli GN; Grassini D; Ortenzi V; Pasqualetti F; Montemurro N; Perrini P; Naccarato AG; Scatena C Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804731 [TBL] [Abstract][Full Text] [Related]
18. HSP47 Promotes Glioblastoma Stemlike Cell Survival by Modulating Tumor Microenvironment Extracellular Matrix through TGF-β Pathway. Jiang X; Zhou T; Wang Z; Qi B; Xia H ACS Chem Neurosci; 2017 Jan; 8(1):128-134. PubMed ID: 27696866 [TBL] [Abstract][Full Text] [Related]
19. Astrocytes and the tumor microenvironment inflammatory state dictate the killing of glioblastoma cells by Smac mimetic compounds. Malone K; Dugas M; Earl N; Alain T; LaCasse EC; Beug ST Cell Death Dis; 2024 Aug; 15(8):592. PubMed ID: 39147758 [TBL] [Abstract][Full Text] [Related]
20. Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting. Persano L; Rampazzo E; Basso G; Viola G Biochem Pharmacol; 2013 Mar; 85(5):612-622. PubMed ID: 23063412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]